Severe community-acquired pneumonia

Seminars in Respiratory and Critical Care Medicine

Volumn 17, Issue 3, 1996, Pages 265-271

  Torres, Antoni ^a   El Ebiary, Mustafa ^a   Zavala, Elisabeth ^a   Hernandez, Carmen ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ERYTHROMYCIN; PROSTACYCLIN; RIFAMPICIN;

ANTIBIOTIC THERAPY; BACTERIOLOGY; DIAGNOSTIC APPROACH ROUTE; DISEASE SEVERITY; HUMAN; MORTALITY; PHYSIOTHERAPY; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; REVIEW; TREATMENT PLANNING;

EID: 0029894059     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-1009897     Document Type: Review

References (33)

1. Vital Health Statistic Series National Hospital Discharge Annual Survey: 1987 Summary. National Center for Health Statistics, Hyatsville, MD,Series 13:1989:99
2. Farr BM, Sloman AJ, Fisch MJ. Predicting death in patients hospitalized for community acquired pneumonia. Ann Intern Med; 1991;115 428-436
3. Torres A, Serra Batlles J, Ferrer A, et al. Severe communityacquired pneumonia. Epidemiology and prognosis factors. Am Rev Respir Dis 1991;144:311-8
4. Guidelines for the initial management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis 1993;148:1418-26
5. Ortqvist A, Sterner G, Nilsson JA. Severe community-acquired pneumonia requiring hospitalization: factors influencing need of intensive care treatment and prognosis. Scand J Infect Dis 1985;17:377-86
6. Alkhayer M, Jenkins PF, Harrison BDW. The outcome of community-acquired pneumonia treated on the intensive care unit Respir Med 1990:84:13-6
7. Marrie TJ, Durant H, Yates L. Community-acquired pneumonia requiring hospitalization: A 5 year prospective study. Rev Infect Dis 1989:11:586-99
8. Pachon J, Prados MD. Capote F, et al. Severe community acquired pneumonia. Etiology, prognosis, and treatment Am Rev Respir Dis 1990:142:369-73
9. Woodhead MA. MacFarlane JT, Rodgers FG, et al. Aetiology and outcome of severe community-acquired pneumonia. J Infect 1985;10:204-10
10. Sorensen J, Cederholm I, Carlsson C. Pneumonia: a deadly disease despite intensive care treatment. Scand J Infect Dis 1986;18:329-35
11. Feldman C, Kallembach JM, Levy H, et al. Communityacquired pneumonia of diverse etiology: prognosis features in patients admitted to an intensive care unit and a "severity of illness." Intensive Care Med 1986;18:329-35
12. Moine P, Vercken JB, Chevret S, et al and the French study group of community-acquired pneumonia in ICU. Severe community-acquired pneumonia. Etiology, epidemiology and prognostic factors. Chest 1994;105:1487-95
13. Lerov O. Santré C, Beuscart B. et al. A five year study of severe community-acquired pneumonia with emphasis on prog-nosis in patients admitted to an intensive care unit. Intensive Care Med 1996;21:24-31
14. Rello J, Quintana E, Ausina V, et al, A three-year study of severe community-acquired pneumonia with emphasis on outcome. Chest 1993;103:232-5
15. Fang GD, Fine M, Orloff J, et al. New and emerging etiologies for community-acquired pneumonia with implication for therapy. A prospective multicenter study of 359 cases. Medicine 1990;69:307-16
16. MacFarlane JT, Miller AC, Smith WHO, et al. Comparative radiographie features of community-acquired Legionnaires disease, pneumococcal pneumonia, Mycoplasma pneumonia and psittacosis. Thorax 1984;39:28-33
17. Granados A, Podzameer D, Gudiol F, Manresa F. Pneumonia due to Legionella pneumophila and pneumococcal pneumonias: similarities and differences of presentation. Eur Respir J 1989;2:130-4
18. Torres A, Jiménez P, Puig de la Bellacasa J, et al. Diagnostic value of nonfluoroscopic percutaneous lung needle aspiration in patients with pneumonia. Chest 1990;98:840-4
19. Ortqvist A, Kalin M, Lejdeborn L, Lundberg B. Diagnostic fiberoptic bronchoscopy and protected brush culture in patients with community-acquired pneumonia. Chest 1990;97:576-82
20. Jimenez P, Saldías F, Meneses M, et al. Diagnostic fiberoptic bronchoscopy in patients with community-acquired pneumonia. Comparison between bronchoalveolar lavage and telescoping plugged catheter cultures. Chest 1993;103:1023-7
21. Torres A, Puig de la Bellacasa J, Xaubet A, et al. Diagnostic value of quantitative cultures of bronchoalveolar lavage and telescoping plugged catheters in mechanically ventilated patients with pneumonia. Am Rev Respir Dis 1989;85:499-506
22. Leeper K, Torres A. Community-acquired pneumonia in the intensive care unit. Clin Chest Med 1995;16:166-70
23. British Thoracic Society and the Public Health Laboratory Service. Community acquired pneumonia in adults in British Hospitals in 1982-83: a survey of aetiology, mortality, prognostic factors and outcome. QJ Med 1987:62:195-220
24. Örtqvist A, Hedlund J, Grillner L, et al Aetiology, outcome and prognostic factors in community-acquired pneumonia requiring hospitalization. Eur Respir J 1990;3:1105-13
25. Ewig S, Bauer E, Hasper L, et al. Prognostic analysis and predictive rule for outcome of hospital-treated communityacquired pneumonia. Eur Respir J 1995;8:392-7
26. Marrie TJ. Epidemiology of community-acquired pneumonia in the elderly. Semin Respir Infect 1990;5:260-8
27. Fink MP, Syndman DR. Niederman MS, et al. Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. Antimicrob Agents Chemother 1994;38:547-57
28. Gea J, Roca J, Torres A, et al. Mechanisms of abnormal gas exchange in patients with pneumonia. Anesthesiology I991;75:782-9
29. Ferrer A, Torres A, Baer R, et al. Effect of acetylsalicylic acid on pulmonary gas exchange in patients with life threatening pneumonia Am J Respir Crit Care Med 1995;151:A232
30. Walmrath D, Schneider CH, Pilch J, et al. Effects of aerosolized prostacyclin in severe pneumonia. Impact of fibrosis. Am J Respir Crit Care Med 1995;151:724-30
31. Dreyffuss D, Djedaini K, Lanore JJ, et al. A comparative study of the effects of almitrine bismesylate and lateral position during unilateral bacterial pneumonia with severe hypoxemia. Am Rev Respir Dis 1992;146:296-9
32. Rossaint R, Falke KJ, Lopez F, et al. Inhaled nitric oxide in adult respiratory distress syndrome. N Engl J Med 1993;328:399-405
33. Örqvist A. Initial investigation and treatment of the patient with severe community acquired pneumonia. Semin Respir Infect 1994;9:166-79